OtherCLINICAL INVESTIGATIONS
Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy
Roser Solans, Josep-Angel Bosch, Pere Galofré, Francesc Porta, José Roselló, Albert Selva-O’Callagan and Miquel Vilardell
Journal of Nuclear Medicine May 2001, 42 (5) 738-743;
Roser Solans
Josep-Angel Bosch
Pere Galofré
Francesc Porta
José Roselló
Albert Selva-O’Callagan
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy
Roser Solans, Josep-Angel Bosch, Pere Galofré, Francesc Porta, José Roselló, Albert Selva-O’Callagan, Miquel Vilardell
Journal of Nuclear Medicine May 2001, 42 (5) 738-743;
Related Articles
- No related articles found.
Cited By...
- Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study
- Administration of Radioactive Iodine Therapy Within 1 Year After Total Thyroidectomy Does Not Affect Vocal Function
- Assessment of Salivary Gland Dysfunction after Radioiodine Therapy for Thyroid Carcinoma Using Non-Contrast-Enhanced CT: The Significance of Changes in Volume and Attenuation of the Glands
- Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
- Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity
- Perspective: The Case Against Radioiodine Remnant Ablation in Patients with Well-Differentiated Thyroid Carcinoma
- Reducing the Incidence of 131I-Induced Sialadenitis: The Role of Pilocarpine
- The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report
- Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer?
- Salivary Gland Scintigraphy: The Use of Semiquantitative Analysis for Uptake and Clearance
- Treatment of Thyroid Carcinoma: Emphasis on High-Dose 131I Outpatient Therapy